1 active not recruiting, 1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow LY03020: new trials by email Literature Review of LY03020 trials Research Report on LY03020
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With Schizophrenia LY03020, Placebo - Schizophrenia | Phase 2 | Not yet recruiting | Luye Pharma Group Ltd. | 160 | 2026-03-31 | 2026-02-09 |
| A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020 LY03020, Placebo - Schizophrenia, Alzheimer's Disease Psychosis | Phase 1 | Recruiting | Luye Pharma Group Ltd. | 40 | 2025-08-20 | 2025-11-19 |
| A Food Effect Study of LY03020 in Healthy Subjects LY03020 - Schizophrenia, Alzheimer's Disease Psychosis | Phase 1 | Active not recruiting | Luye Pharma Group Ltd. | 16 | 2025-07-30 | 2025-12-18 |
| A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects LY03020, Placebo - Schizophrenia, Alzheimer's Disease Psychosis | Phase 1 | Completed | Luye Pharma Group Ltd. | 66 | 2024-08-19 | 2025-05-29 |
Schizophrenia (4)
China (4)
Gang Wang (1)